6Miloservic DB. The different level of immunological recovery after chemotherapy in leukemia and lymphoma patients [ J ]. J Exp Clin Cancer Res, 2002 ;21:517-522.
7Ek T Mellander L Andersson B Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer, 2005 May;44(5) : 461-8.
8Mazur B, Szezepafiski T, Karpe J, et al. Decreased numbers of CD4^+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia. Leuk Res, 2006 Jan;30( 1 ) :33-6.
9Smith S, Sehiffman G karayalcin C4 et al. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy. J Pediatr, 1995 ;127:68-75.
1[1]No authers listed. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies sepsis[J].Crit Care Med,1992,20:864-874
2[2]Bone RC,Balk RA,Cerra FB,et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101:1644-1655
4[4]Bone RC. Immunologic dissonance:a continuing evolution in our understanding of the systemic inflammatory responsc syndrome(SIRS)and the multiplc organ dysfunction syndrome[J].Ann Intern Med,1996,125:680-687
5[5]Dofferhoff AS,Bom VJ,de Vries-Hospers HG,et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and actue-phase proteins during the treatment of severe sepsis in humans[J].Crit Care Med,1992,20:185-192
6[6]Reinhart K,Weigand-Lohnert C,Grimminger F,et al.Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment,MAK 195F,in patients with sepsis and septic shock:a multicenter,randomized,placebo controlled,dose-ranging study[J].Crit Care Med,1996,24:733-742
7[7]Starnes HF,Pearec MK,Tewari A,et al.Anti-IL-6 monoelonal antibodies protect against Lethal Escherichia coli infection and leathal tumor necrosis factor alpha challenge in mice[J].J Immunol,1990,145:4185-4191
8[8]Deutschman CS.Acute phase response and SIRS/MODS:the good,the bad, and the nebulous[J].Crit Care Med,1998,26:1630-1631
9[9]Bone RC. Sir Isaac Newton, Sepsis,SIRS, and CARS[J].Crit Care Med,1996,24:1125-1128
10[10]Hughes CB,Caber LW,Mohey AB,et al.Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis[J].Am Surg,1996,62:8-13
3Armitage J O. Targeted therapy and hematological malignancy [J]. Target Oncol,2009,4(1) :1-2.
4Cho W C, Leung K N. In vitro and in vivo immuno-modulating and immuno-restorative effects of Astragalusmembra naceus [J]. J Ethnopharmacology,2007,113(1) : 132-141.
